MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 31.07.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
694 M |
Marktkapitalisierung |
$ 791 M |
EBITDA (LTM) |
$ -79.8 M |
P/E (LTM) |
-4.42 |
P/S (LTM) |
1.2 |
EPS (LTM) |
-0.26 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Biodesix
BDSX
|
$ 15.21 | 3.54 % | $ 1.97 B | Nasdaq Global Market | USA |
 |
Bioventus
BVS
|
$ 9.12 | 1.33 % | $ 608 M | Nasdaq Global Select Market | USA |
 |
Biomerica
BMRA
|
$ 2.12 | -0.47 % | $ 4.87 M | Nasdaq Capital Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.37 | 0.24 % | $ 495 M | Nasdaq Global Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Lantheus Holdings
LNTH
|
$ 75.01 | -0.96 % | $ 5.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 460.9 | 0.87 % | $ 13.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Myriad Genetics
MYGN
|
$ 4.77 | 2.36 % | $ 442 M | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.42 | -0.51 % | $ 390 M | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.39 | -0.36 % | $ 417 M | Nasdaq Global Select Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Precipio
PRPO
|
$ 26.85 | -0.3 % | $ 34.8 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 7.7 | 1.18 % | $ 456 M | Nasdaq Global Select Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
RadNet
RDNT
|
$ 60.0 | -2.83 % | $ 4.51 B | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 159.79 | 1.13 % | $ 7.92 B | NYSE,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 165.38 | -0.95 % | $ 28.4 B | NYSE,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 6.74 | 1.81 % | $ 281 M | NYSE American | USA |
 |
Sotera Health Company
SHC
|
$ 13.89 | 0.07 % | $ 3.94 B | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.24 | -15.07 % | $ 6.75 M | Nasdaq Capital Market,SPB | USA |
 |
Neuronetics
STIM
|
$ 1.49 | -7.19 % | $ 98.3 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 256.48 | 1.41 % | $ 25.9 B | NYSE,SPB |  Schweiz |
 |
Interpace Biosciences
IDXG
|
$ 1.71 | 0.73 % | $ 7.5 M | Nasdaq Global Select Market | USA |
 |
IDEXX Laboratories
IDXX
|
$ 574.14 | -0.76 % | $ 46.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 125.44 | 1.33 % | $ 19.9 B | Nasdaq Global Select Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 101.04 | 0.68 % | $ 8.33 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Guardant Health
GH
|
$ 85.0 | 0.05 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
$ 45.99 | 3.35 % | $ 2.75 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 103.41 | -3.13 % | $ 4.08 B | Nasdaq Global Select Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 265.75 | 0.5 % | $ 22.1 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
ENDRA Life Sciences
NDRA
|
$ 3.36 | -3.45 % | $ 1.8 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 8.05 | -0.62 % | $ 1.03 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 195.23 | -2.43 % | $ 19.2 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 17.58 | 0.11 % | $ 937 M | Nasdaq Global Market,SPB | USA |